Pharmacists disease state management through a collaborative practice model

Journal of Health Care for the Poor and Underserved

Volumn 16, Issue 2, 2005, Pages 220-224

  Leal, Sandra ^a   Soto, Marisa ^a  

^a El Rio Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE SYSTEM; HEALTH CENTER; HIGH RISK POPULATION; LAW; MEDICAL PRACTICE; PHARMACIST; UNITED STATES;

ARIZONA; COOPERATIVE BEHAVIOR; DIABETES MELLITUS; DISEASE MANAGEMENT; HUMANS; INTERPROFESSIONAL RELATIONS; MODELS, ORGANIZATIONAL; PATIENT CARE TEAM; PHARMACISTS; PILOT PROJECTS; PRESCRIPTIONS, DRUG; PROFESSIONAL AUTONOMY; UNITED STATES;

EID: 21644457280     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.2005.0039     Document Type: Article

References (17)

1. American Diabetes Association (ADA). National diabetes fact sheet. Alexandria, VA: ADA, 2003.
2. Hogan P, Dall T, Nikolov P: Economic costs of diabetes in the US in 2002. Diabetes Care 2003 Mar; 26(3):917-32.
3. Committee on the Consequences of Uninsurance. Insuring America's Health: Principles and Recommendations. Washington, DC: Board on Health Care Services, Institute of Medicine, 2004.
4. National Committee for Quality Assurance (NCQA). State of health care quality, 2003. Washington, DC: NCQA, September 2003.
5. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998 Jun; 32(6):636-41.
6. Anderson PO, Taryle DA. Pharmacist management of ambulatory patients using formalized standards of care. Am J Hosp Pharm 1974 Mar; 31(3):254-7.
7. Johnson RE, Tuchler RJ. Role of the pharmacist in primary health care. Am J Hosp Pharm 1975 Feb; 32(2):162-4.
8. Erickson SH. Primary care by a pharmacist in an outpatient clinic. Am J Hosp Pharm 1977 Oct; 34(10):1086-90.
9. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001 Nov; 21(11):1337-44.
10. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000 Mar-Apr; 40(2):157-65.
11. Kelley C, Rodgers PT. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm 2000; 6:488-493.
12. Cranor CW, Christensen DB. The Ashville project: short-term outcomes of a community pharmacy-based diabetes care program. J Am Pharm Assoc 2003 Mar-Apr;43(2):149-59.
13. Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 2005 Jan;25(1):96-109.
14. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001 Mar-Apr; 41(2):192-9.
15. Knapp KK, Okamota MP, Black BL. ASHP survey of ambulatory care pharmacy practice in health systems: 2004. Am J Health Syst Pharm 2005 Feb;62(3):274-84.
16. Herrier RN, Boyce RW, Apgar DA. Pharmacist-managed patient care services and prescriptive authority in the U.S. Public Health Service. Hosp Formul 1990 Jan;25(1):67-8, 76-8, 80.
17. Leal S, Herrier RN, Glover JJ, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 2004 Dec;27(12):2983-4.